Category Archives: Advertising

Why the Delay on Facts Boxes?

By Ben Comer | Published: November 16, 2011
Despite a near-complete absence of criticism coming from industry, academia, clinicians and patients, the drug facts box – a concise, quantitative, easy-to-read format for presenting a drug’s risk/benefit profile in print advertisements – seems at least three years away from launch.
Also posted in FDA, Legal, Marketing, Regulatory, Strategy, patient education | Tagged | 1 Comment

Pfizer CEO: DTC a 'Fundamental Right'

By Ben Comer | Published: October 5, 2011
Direct-to-consumer (DTC) advertising is a “fundamental right in the U.S.,” and denying the right of industry to speak directly to patients through drug advertising “leads to ignorance and the inability to judge,” said Ian Read, Pfizer’s president and CEO, at the Cleveland Clinic on Tuesday. Asked whether DTC ads on television should be retired, Read answered [...]
Also posted in IP, Marketing, Patient Communication, Regulatory, Strategy, leadership, patient education | Tagged , | 7 Comments

The HCR Taxman Cometh

By Guest Blogger | Published: September 13, 2011
By Tom Norton As the country struggles with the current economic malaise, and the pharmaceutical industry enters into yet another difficult quarter of “trying to make the numbers,” one matter that I doubt many Rx execs are thinking about today is the HCR Taxman.  That’s too bad.  They probably should.  That’s because he’s coming for the [...]
Also posted in Agency Insight, Biotech, Corporate Responsibility, Strategy, compliance | Comments closed

Without An Rx, Some Pharmas Are Skittish

By Ben Comer | Published: August 24, 2011
Lower margins and strong-arm direct-to-consumer campaigns are two of the primary barriers to selling nutraceuticals, according to a business school ‘war game’ conducted with the participation of Abbott, Danone (Dannon in the US), GSK and Nestlé. But the global nutraceuticals market – worth $80 billion in 2010, according to Frost & Sullivan – is expected [...]
Also posted in Global, IP, Marketing, Regulatory, Strategy, patient education | Tagged , , , | 4 Comments

DIA: Social Media Guidelines are DDMAC’s "Highest Priority"

By Ben Comer | Published: June 22, 2011
Tom Abrams, director of FDA’s Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), said that publishing social media guidelines for industry is the division’s “highest priority,” and that the document will be “published as soon as it’s vetted.”
Also posted in E-Media, FDA, Marketing, Meetings, Regulatory, Strategy, Technology, patient education, social media | Tagged , , | 1 Comment